Data Critical inks deal with Agilent for wireless
Data Critical and Agilent Technologies have signed a three-year agreement under which the Agilent Information Center will integrate Data Critical's StatView wireless alarm notification system into its monitoring network. The StatView system
Data Critical and Agilent Technologies have signed a three-year agreement under which the Agilent Information Center will integrate Data Critical's StatView wireless alarm notification system into its monitoring network. The StatView system transmits ECG waveforms and other vital signs information directly to a pager-style wireless device. Agilent plans to make the StatView technology available in its monitoring systems in 2001.
In related news, Data Critical has teamed up with Nextel Communications to distribute Data Critical's unwiredDr wireless Web services to Nextel's subscribers in the healthcare industry. The firms will jointly market the services on a low-cost, subscription basis.
© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 7.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
